Literature DB >> 21874644

Linguistic validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian patients.

Ali Gholamrezaei1, Behzad Zolfaghari, Ziba Farajzadegan, Kianoosh Nemati, Hamed Daghaghzadeh, Hamid Tavakkoli, Mohammad Hassan Emami.   

Abstract

There is a growing interest of clinical and epidemiological researches in the field of functional gastrointestinal disorders in our society. Accordingly, validated and culturally adapted instruments are required for appropriate measurement of variables specially the quality of life. The aim of our study was the linguistic validation of the Irritable Bowel Syndrome-Quality of Life questionnaire (IBS-QOL) for Iranian IBS patients with Persian language. Following the standard forward-backward translation method, the IBS-QOL was translated into the Persian language and completed by 141 IBS patients. Patients also completed the IBS Symptom Severity Scale (IBS-SSS) and Hospital Anxiety and Depression Scale (HADS). One-week retest was performed on 30 randomly selected patients. Internal consistency and test-retest reliability were assessed using Cronbach's alpha and intraclass correlation coefficient (ICC), respectively. To analyze the discriminant validity, the IBS-QOL scores was correlated to the IBS-SSS and HADS scores. According to the results, reliability analyses were acceptable for all of the IBS-QOL domains (Cronbach's alpha=0.68 to 0.90 and ICCs=0.77 to 0.91). Discriminant validity was supported by the presence of correlations of the IBS-QOL scores with disease severity (r = -0.628), depression (r = -0.692), and anxiety (r = -0.711) scores; P < 0.001. These results indicate that the Persian version of the IBS-QOL is a reliable instrument with sufficient psychometric requirements to assess quality of life in Iranian IBS patients with Persian language.

Entities:  

Mesh:

Year:  2011        PMID: 21874644

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  13 in total

1.  Evaluation of health related quality of life in irritable bowel syndrome patients.

Authors:  Raika Jamali; Arsia Jamali; Maryam Poorrahnama; Abdollah Omidi; Bardia Jamali; Neda Moslemi; Reza Ansari; Shahab Dolatshahi; Naser Ebrahimi Daryani
Journal:  Health Qual Life Outcomes       Date:  2012-01-29       Impact factor: 3.186

2.  Zinc nutritional status, mood states and quality of life in diarrhea-predominant irritable bowel syndrome: a case-control study.

Authors:  Mahsa Rezazadegan; Farnaz Shahdadian; Maryam Soheilipour; Mohammad Javad Tarrahi; Reza Amani
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

Review 3.  A systematic review of measurement properties of the instruments measuring health-related quality of life in patients with irritable bowel syndrome.

Authors:  Jiyeon Lee; Eun-Hyun Lee; Seung Hei Moon
Journal:  Qual Life Res       Date:  2016-09-29       Impact factor: 4.147

4.  Prevalence and predictors of irritable bowel syndrome among medical students and interns in King Abdulaziz University, Jeddah.

Authors:  Nahla Khamis Ragab Ibrahim; Wijdan Fahad Battarjee; Samia Ahmed Almehmadi
Journal:  Libyan J Med       Date:  2013-09-19       Impact factor: 1.743

5.  Soy Isoflavones Supplementation for Patients with Irritable Bowel Syndrome: A Randomized Double Blind Clinical Trial.

Authors:  Mahsa Jalili; Homayoon Vahedi; Leila Janani; Hossein Poustchi; Reza Malekzadeh; Azita Hekmatdoost
Journal:  Middle East J Dig Dis       Date:  2015-07

6.  Validity, reliability, and factor analysis of Persian version of quality of life questionnaire for irritable bowel syndrome (IBS-QOL-34).

Authors:  Nasrine Masaeli; Gholam Reza Kheirabadi; Hamid Afshar; Hamed Daghaghzadeh; Mohammad Reza Maracy; F Assadolahi; Peiman Adibi
Journal:  J Res Med Sci       Date:  2013-06       Impact factor: 1.852

7.  Health related quality of life in irritable bowel syndrome patients, Kashan, Iran: A case control study.

Authors:  Raika Jamali; Mostafa Raisi; Mohammad Matini; Alireza Moravveji; Abdollah Omidi; Jaleh Amini
Journal:  Adv Biomed Res       Date:  2015-03-25

8.  Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease.

Authors:  Mahsa Jalili; Azita Hekmatdoost; Homayoon Vahedi; Hossein Poustchi; Behnam Khademi; Mohsen Saadi; Maryam Zemestani; Leila Janani
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

9.  The effects of multi-strain probiotic compound on symptoms and quality-of-life in patients with irritable bowel syndrome: A randomized placebo-controlled trial.

Authors:  Ahmad Shavakhi; Mohammad Minakari; Somaye Farzamnia; Mohammad Saleh Peykar; Golshan Taghipour; Azadeh Tayebi; Huriyeh Hashemi; Sara Shavakhi
Journal:  Adv Biomed Res       Date:  2014-06-25

10.  Irritable bowel syndrome-specific health-related quality of life instrument: development and psychometric evaluation.

Authors:  Eun-Hyun Lee; Oran Kwon; Ki Baik Hahm; WonHee Kim; Jin Il Kim; Dae Young Cheung; Yoon Jae Kim; Jung Ho Kim; Jong-Jae Park; Moon Kyung Joo
Journal:  Health Qual Life Outcomes       Date:  2016-02-17       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.